InspireMD, Inc.NSPR

$0.71-0.03 (-3.79%)
NASDAQHealthcare24:00 UTC

Company snapshot

Market Cap
$52M
Micro-cap
+2521%
2016 — today
10-Year Price
-100%
2016 — today
52-Week Range
$0.71$2.79
Current $0.71· 0%

InspireMD, Inc., an Israel-based medical technology company established in 2005, specializes in creating and commercializing advanced medical devices. Its core expertise lies in the proprietary MicroNet stent platform technology, engineered to address various vascular and coronary diseases. The company's offerings, distributed through a network of local partners, reach markets across Europe, Latin America, the Middle East, and Asia Pacific. Key products include the CGuard carotid embolic prevention system, specifically designed for carotid artery procedures, and the MGuard Prime embolic protection systems. The MGuard Prime systems are crucial for patients experiencing acute coronary syndromes, notably acute myocardial infarction, and those undergoing saphenous vein graft coronary interventions or bypass surgery. InspireMD is also developing PVGuard, an innovative solution combining a MicroNet mesh sleeve with a self-expandable stent, aimed at peripheral vascular applications.

Valuation in context

P/E ratio
-1.3
N/A
Not meaningful — company is unprofitable
P/B ratio
1.2
Above average
Pricier than usual over the last 10 years
FCF Yield
-77.0%
Around average
Around the 10-year average
Free · No credit card needed

Get alerted when NSPR is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.